Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'. (5th May 2018)

Record Type:: Journal Article
Title:: Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'. (5th May 2018)
Main Title:: Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
Authors:: Schöffski, P
Wozniak, A
Stacchiotti, S
Rutkowski, P
Blay, J -Y
Lindner, L H
Strauss, S J
Anthoney, A
Duffaud, F
Richter, S
Grünwald, V
Leahy, M G
Reichardt, P
Sufliarsky, J
van der Graaf, W T
Sciot, R
Debiec-Rychter, M
van Cann, T
Marréaud, S
Lia, M
Raveloarivahy, T
Collette, L
Bauer, S
Abstract:
Is Part Of:: Annals of oncology. Volume 30:Number 2(2019)
Journal:: Annals of oncology
Issue:: Volume 30:Number 2(2019)
Issue Display:: Volume 30, Issue 2 (2019)
Year:: 2019
Volume:: 30
Issue:: 2
Issue Sort Value:: 2019-0030-0002-0000
Page Start:: 344
Page End:: 344
Publication Date:: 2018-05-05
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx823 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 11987.xml